Ergebnis ihrer Suche nach Mitteilungen

EQS-News 30.11.21 14:00 EQS-News: Dufry International AG
Hudson Booksellers Shares Its “Best of 2021” Collection
EQS-Ad-hoc 28.10.21 07:00 EQS-Ad-hoc: Dufry International AG
Dufry reports acceleration on turnover and strong positive cas[...]
EQS-News 14.10.21 18:00 EQS-News: Dufry International AG
Invitation to Dufry’s Third Quarter 2021 Trading Update
EQS-News 14.10.21 15:12 EQS-News: Dufry International AG
Hudson Cooks Up New Restaurant, Plum Market, At Dallas Fort Wo[...]
EQS-News 06.10.21 14:00 EQS-News: Dufry International AG
Hudson Reveals Transformed Brookstone Experience In North Amer[...]
EQS-News 30.09.21 07:00 EQS-News: Dufry International AG
Dufry extends its Cambodia duty-free concession with three air[...]
EQS-Ad-hoc 24.09.21 07:00 EQS-Ad-hoc: Dufry International AG
Dufry expects positive impact from a new Spanish law, linking [...]
EQS-News 22.09.21 17:41 EQS-News: Dufry International AG
Hudson Celebrates Return To New York City’s Historic Grand Cen[...]
EQS-News 19.08.21 07:00 EQS-News: Dufry International AG
Dufry renews its contract with Cardiff Airport for 12 years
EQS-Ad-hoc 10.08.21 07:01 EQS-Ad-hoc: Dufry International AG
Dufry with gradual recovery worldwide and continued progress o[...]
EQS-News 05.08.21 17:35 EQS-News: Dufry International AG
Hudson Debuts Expansive Shop-In-Shop Experience Store – Evolve[...]
EQS-News 03.08.21 07:00 EQS-News: Dufry International AG
Dufry extends for ten years its duty-free concession at the Sa[...]
EQS-News 26.07.21 07:00 EQS-News: Dufry International AG
Invitation to Dufry’s Half-Year Results 2021 Conference Call o[...]
EQS-Ad-hoc 10.06.21 07:01 EQS-Ad-hoc: Dufry International AG
Dufry wins new, ten-year duty-free contract at Martinique Inte[...]

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Symrise verlängert Vorstandsvertrag von Dr. Heinz-Jürgen Bertram vorzeitig bis 2025

01. Dezember 2021, 15:38

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

Original-Research: GBC Insider Focus Index (von GBC AG): GBC Insider Focus Index

01. Dezember 2021